ArticleJournal of clinical and translational science2022
KL2 scholars' perceptions of factors contributing to sustained translational science career success.
Article in Journal of clinical and translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Trial
- Outcomes of the NCI cancer prevention fellowship program: a focus on mentorship within a multidisciplinary public health field.BMC medical education · 2026Article
- Outcomes of the NCI cancer prevention fellowship program in training multidisciplinary public health professional leaders.Scientific reports · 2026Article
- Academic influencers: Clinical and Translational Science scholars and trainees at the intersection of influential scholarship and public attention.Journal of clinical and translational science · 2025Article
- A scoping review of mentorship in a CTSA context: A summary of past work and an agenda for future research.Journal of clinical and translational science · 2025Review
- The development, validity, and reliability of the Researcher Investment Tool.Journal of clinical and translational science · 2025Article
- Approaches and tools to measure individual-level research experience, activities, and outcomes: A narrative review.Journal of clinical and translational science · 2025Review
- Internal Consistency and Application of a Mentee Survey to Assess Mentor Competencies in an Academic Medical Center across Demographic Groups.The chronicle of mentoring & coaching · 2024Article
- DEIA is essential to advance the goals of translational science: Perspectives from NCATS.Journal of clinical and translational science · 2023Article
- Customized Career Development Platform (CCDP) for clinical and translational researchers: A pragmatic cluster-randomized controlled trial.Journal of clinical and translational science · 2023Article
- Ten simple rules for launching an academic research career.PLoS computational biology · 2022Article
- Advancing translational science education.Clinical and translational science · 2022Review
- Teaching principles of translational science to a broad scientific audience using a case study approach: A pilot course from the National Center for Advancing Translational Sciences.Journal of clinical and translational science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Introduction: Identifying the most effective ways to support career development of early stage investigators in clinical and translational science should yield benefits for the biomedical research community. Institutions with Clinical and Translational Science Awards (CTSA) offer KL2 programs to facilitate career development; however, the sustained impact has not been widely assessed. Methods: A survey comprised of quantitative and qualitative questions was sent to 2144 individuals that had previously received support through CTSA KL2 mechanisms. The 547 responses were analyzed with identifying information redacted. Results: Respondents held MD (47%), PhD (36%), and MD/PhD (13%) degrees. After KL2 support was completed, physicians' time was divided 50% to research and 30% to patient care, whereas PhD respondents devoted 70% time to research. Funded research effort averaged 60% for the cohort. Respondents were satisfied with their career progression. More than 95% thought their current job was meaningful. Two-thirds felt confident or very confident in their ability to sustain a career in clinical and translational research. Factors cited as contributing to career success included protected time, mentoring, and collaborations. Conclusion: This first large systematic survey of KL2 alumni provides valuable insight into the group's perceptions of the program and outcome information. Former scholars are largely satisfied with their career choice and direction, national recognition of their expertise, and impact of their work. Importantly, they identified training activities that contributed to success. Our results and future analysis of the survey data should inform the framework for developing platforms to launch sustaining careers of translational scientists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.